 | • レポートコード：QAF26946 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアレルギー免疫療法市場について種類別（皮下免疫療法、舌下免疫療法）、用途別（アレルギー性鼻炎、アレルギー性喘息、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アレルギー免疫療法市場の概要 ・世界の主要地域別アレルギー免疫療法市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアレルギー免疫療法市場規模2016-2021：種類別（皮下免疫療法、舌下免疫療法） ・世界のアレルギー免疫療法市場予測2012-2027：種類別（皮下免疫療法、舌下免疫療法） ・世界のアレルギー免疫療法市場規模2016-2021：用途別（アレルギー性鼻炎、アレルギー性喘息、その他） ・世界のアレルギー免疫療法市場予測2012-2027：用途別（アレルギー性鼻炎、アレルギー性喘息、その他） ・アレルギー免疫療法のアメリカ市場規模と予測2016-2021 ・アレルギー免疫療法のヨーロッパ市場規模と予測2016-2021 ・アレルギー免疫療法の中国市場規模と予測2016-2021 ・アレルギー免疫療法の日本市場規模と予測2016-2021 ・アレルギー免疫療法の東南アジア市場規模と予測2016-2021 ・アレルギー免疫療法のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ALK-Abello、Stallergenes Greer、Merck、Allergy Therapeutics、HAL、Holister Stier、Leti） ・アレルギー免疫療法の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アレルギー免疫療法の市場動向・機会・課題 ・調査の結論 |
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system’s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The classification of Allergy Immunotherapy includes Subcutaneous Immunotherapy and Sublingual Immunotherapy. The proportion of Subcutaneous Immunotherapy in EMEA in 2019 is about 61.58%, and the proportion of Sublingual Immunotherapy in 2019 is about 38.42%.
Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.56 % in EMEA in 2019.
Europe is the largest consumption place, with a consumption market share nearly 95.59% in EMEA in 2019, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction.
Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 83.92% in in EMEA 2019.
Market Analysis and Insights: Global Allergy Immunotherapy Market
The global Allergy Immunotherapy market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Allergy Immunotherapy Scope and Market Size
The global Allergy Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergy Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Others
The Allergy Immunotherapy market is analysed and market size information is provided by regions (countries). Segment by Application, the Allergy Immunotherapy market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
1 Allergy Immunotherapy Market Overview
1.1 Allergy Immunotherapy Product Scope
1.2 Allergy Immunotherapy Segment by Type
1.2.1 Global Allergy Immunotherapy Sales by Type (2016 & 2021 & 2027)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Allergy Immunotherapy Segment by Application
1.3.1 Global Allergy Immunotherapy Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Others
1.4 Allergy Immunotherapy Market Estimates and Forecasts (2016-2027)
1.4.1 Global Allergy Immunotherapy Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Allergy Immunotherapy Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Allergy Immunotherapy Price Trends (2016-2027)
2 Allergy Immunotherapy Estimates and Forecasts by Region
2.1 Global Allergy Immunotherapy Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Allergy Immunotherapy Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Allergy Immunotherapy Sales Market Share by Region (2016-2021)
2.2.2 Global Allergy Immunotherapy Revenue Market Share by Region (2016-2021)
2.3 Global Allergy Immunotherapy Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Allergy Immunotherapy Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Allergy Immunotherapy Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Allergy Immunotherapy Estimates and Projections (2016-2027)
2.4.2 Europe Allergy Immunotherapy Estimates and Projections (2016-2027)
2.4.3 China Allergy Immunotherapy Estimates and Projections (2016-2027)
2.4.4 Japan Allergy Immunotherapy Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Allergy Immunotherapy Estimates and Projections (2016-2027)
2.4.6 India Allergy Immunotherapy Estimates and Projections (2016-2027)
3 Global Allergy Immunotherapy Competition Landscape by Players
3.1 Global Top Allergy Immunotherapy Players by Sales (2016-2021)
3.2 Global Top Allergy Immunotherapy Players by Revenue (2016-2021)
3.3 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2020)
3.4 Global Allergy Immunotherapy Average Price by Company (2016-2021)
3.5 Manufacturers Allergy Immunotherapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Allergy Immunotherapy Market Size by Type
4.1 Global Allergy Immunotherapy Historic Market Review by Type (2016-2021)
4.1.1 Global Allergy Immunotherapy Sales Market Share by Type (2016-2021)
4.1.2 Global Allergy Immunotherapy Revenue Market Share by Type (2016-2021)
4.1.3 Global Allergy Immunotherapy Price by Type (2016-2021)
4.2 Global Allergy Immunotherapy Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Allergy Immunotherapy Sales Forecast by Type (2022-2027)
4.2.2 Global Allergy Immunotherapy Revenue Forecast by Type (2022-2027)
4.2.3 Global Allergy Immunotherapy Price Forecast by Type (2022-2027)
5 Global Allergy Immunotherapy Market Size by Application
5.1 Global Allergy Immunotherapy Historic Market Review by Application (2016-2021)
5.1.1 Global Allergy Immunotherapy Sales Market Share by Application (2016-2021)
5.1.2 Global Allergy Immunotherapy Revenue Market Share by Application (2016-2021)
5.1.3 Global Allergy Immunotherapy Price by Application (2016-2021)
5.2 Global Allergy Immunotherapy Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Allergy Immunotherapy Sales Forecast by Application (2022-2027)
5.2.2 Global Allergy Immunotherapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Allergy Immunotherapy Price Forecast by Application (2022-2027)
6 North America Allergy Immunotherapy Market Facts & Figures
6.1 North America Allergy Immunotherapy Sales by Company
6.1.1 North America Allergy Immunotherapy Sales by Company (2016-2021)
6.1.2 North America Allergy Immunotherapy Revenue by Company (2016-2021)
6.2 North America Allergy Immunotherapy Sales Breakdown by Type
6.2.1 North America Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
6.2.2 North America Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
6.3 North America Allergy Immunotherapy Sales Breakdown by Application
6.3.1 North America Allergy Immunotherapy Sales Breakdown by Application (2016-2021)
6.3.2 North America Allergy Immunotherapy Sales Breakdown by Application (2022-2027)
7 Europe Allergy Immunotherapy Market Facts & Figures
7.1 Europe Allergy Immunotherapy Sales by Company
7.1.1 Europe Allergy Immunotherapy Sales by Company (2016-2021)
7.1.2 Europe Allergy Immunotherapy Revenue by Company (2016-2021)
7.2 Europe Allergy Immunotherapy Sales Breakdown by Type
7.2.1 Europe Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
7.2.2 Europe Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
7.3 Europe Allergy Immunotherapy Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Allergy Immunotherapy Market Facts & Figures
8.1 China Allergy Immunotherapy Sales by Company
8.1.1 China Allergy Immunotherapy Sales by Company (2016-2021)
8.1.2 China Allergy Immunotherapy Revenue by Company (2016-2021)
8.2 China Allergy Immunotherapy Sales Breakdown by Type
8.2.1 China Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
8.2.2 China Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
8.3 China Allergy Immunotherapy Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan Allergy Immunotherapy Market Facts & Figures
9.1 Japan Allergy Immunotherapy Sales by Company
9.1.1 Japan Allergy Immunotherapy Sales by Company (2016-2021)
9.1.2 Japan Allergy Immunotherapy Revenue by Company (2016-2021)
9.2 Japan Allergy Immunotherapy Sales Breakdown by Type
9.2.1 Japan Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
9.2.2 Japan Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
9.3 Japan Allergy Immunotherapy Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Allergy Immunotherapy Market Facts & Figures
10.1 Southeast Asia Allergy Immunotherapy Sales by Company
10.1.1 Southeast Asia Allergy Immunotherapy Sales by Company (2016-2021)
10.1.2 Southeast Asia Allergy Immunotherapy Revenue by Company (2016-2021)
10.2 Southeast Asia Allergy Immunotherapy Sales Breakdown by Type
10.2.1 Southeast Asia Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Allergy Immunotherapy Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Allergy Immunotherapy Market Facts & Figures
11.1 India Allergy Immunotherapy Sales by Company
11.1.1 India Allergy Immunotherapy Sales by Company (2016-2021)
11.1.2 India Allergy Immunotherapy Revenue by Company (2016-2021)
11.2 India Allergy Immunotherapy Sales Breakdown by Type
11.2.1 India Allergy Immunotherapy Sales Breakdown by Type (2016-2021)
11.2.2 India Allergy Immunotherapy Sales Breakdown by Type (2022-2027)
11.3 India Allergy Immunotherapy Sales Breakdown by Application
11.3.1 India Allergy Immunotherapy Sales Breakdown by Application (2016-2021)
11.3.2 India Allergy Immunotherapy Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Allergy Immunotherapy Business
12.1 ALK-Abello
12.1.1 ALK-Abello Corporation Information
12.1.2 ALK-Abello Business Overview
12.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ALK-Abello Allergy Immunotherapy Products Offered
12.1.5 ALK-Abello Recent Development
12.2 Stallergenes Greer
12.2.1 Stallergenes Greer Corporation Information
12.2.2 Stallergenes Greer Business Overview
12.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Stallergenes Greer Allergy Immunotherapy Products Offered
12.2.5 Stallergenes Greer Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Allergy Immunotherapy Products Offered
12.3.5 Merck Recent Development
12.4 Allergy Therapeutics
12.4.1 Allergy Therapeutics Corporation Information
12.4.2 Allergy Therapeutics Business Overview
12.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Allergy Therapeutics Allergy Immunotherapy Products Offered
12.4.5 Allergy Therapeutics Recent Development
12.5 HAL
12.5.1 HAL Corporation Information
12.5.2 HAL Business Overview
12.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 HAL Allergy Immunotherapy Products Offered
12.5.5 HAL Recent Development
12.6 Holister Stier
12.6.1 Holister Stier Corporation Information
12.6.2 Holister Stier Business Overview
12.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Holister Stier Allergy Immunotherapy Products Offered
12.6.5 Holister Stier Recent Development
12.7 Leti
12.7.1 Leti Corporation Information
12.7.2 Leti Business Overview
12.7.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Leti Allergy Immunotherapy Products Offered
12.7.5 Leti Recent Development
…
13 Allergy Immunotherapy Manufacturing Cost Analysis
13.1 Allergy Immunotherapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Allergy Immunotherapy
13.4 Allergy Immunotherapy Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Allergy Immunotherapy Distributors List
14.3 Allergy Immunotherapy Customers
15 Market Dynamics
15.1 Allergy Immunotherapy Market Trends
15.2 Allergy Immunotherapy Drivers
15.3 Allergy Immunotherapy Market Challenges
15.4 Allergy Immunotherapy Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Allergy Immunotherapy Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Allergy Immunotherapy Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Allergy Immunotherapy Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Allergy Immunotherapy Sales (K Units) by Region (2016-2021)
Table 5. Global Allergy Immunotherapy Sales Market Share by Region (2016-2021)
Table 6. Global Allergy Immunotherapy Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Allergy Immunotherapy Revenue Share by Region (2016-2021)
Table 8. Global Allergy Immunotherapy Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Allergy Immunotherapy Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Allergy Immunotherapy Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Allergy Immunotherapy Revenue Share Forecast by Region (2022-2027)
Table 12. Global Allergy Immunotherapy Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Allergy Immunotherapy Sales Share by Company (2016-2021)
Table 14. Global Allergy Immunotherapy Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Allergy Immunotherapy Revenue Share by Company (2016-2021)
Table 16. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergy Immunotherapy as of 2020)
Table 17. Global Allergy Immunotherapy Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Allergy Immunotherapy Manufacturing Sites and Area Served
Table 19. Manufacturers Allergy Immunotherapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Allergy Immunotherapy Sales (K Units) by Type (2016-2021)
Table 22. Global Allergy Immunotherapy Sales Share by Type (2016-2021)
Table 23. Global Allergy Immunotherapy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Allergy Immunotherapy Price (USD/Unit) by Type (2016-2021)
Table 25. Global Allergy Immunotherapy Sales Share by Type (2022-2027)
Table 26. Global Allergy Immunotherapy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Allergy Immunotherapy Revenue Share by Type (2022-2027)
Table 28. Global Allergy Immunotherapy Price (USD/Unit) by Type (2022-2027)
Table 29. Global Allergy Immunotherapy Sales (K Units) by Application (2016-2021)
Table 30. Global Allergy Immunotherapy Sales Share by Application (2016-2021)
Table 31. Global Allergy Immunotherapy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Allergy Immunotherapy Price (USD/Unit) by Application (2016-2021)
Table 33. Global Allergy Immunotherapy Sales (K Units) by Application (2022-2027)
Table 34. Global Allergy Immunotherapy Sales Share by Application (2022-2027)
Table 35. Global Allergy Immunotherapy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Allergy Immunotherapy Revenue Share by Application (2022-2027)
Table 37. Global Allergy Immunotherapy Price (USD/Unit) by Application (2022-2027)
Table 38. North America Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 39. North America Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 40. North America Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 42. North America Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 43. North America Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 44. North America Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 45. North America Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 46. North America Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 47. North America Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 48. North America Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 49. North America Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 50. Europe Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 51. Europe Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 52. Europe Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 54. Europe Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 55. Europe Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 56. Europe Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 57. Europe Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 58. Europe Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 59. Europe Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 60. Europe Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 61. Europe Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 62. China Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 63. China Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 64. China Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 66. China Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 67. China Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 68. China Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 69. China Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 70. China Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 71. China Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 72. China Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 73. China Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 74. Japan Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 75. Japan Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 76. Japan Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 78. Japan Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 79. Japan Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 80. Japan Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 81. Japan Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 82. Japan Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 83. Japan Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 84. Japan Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 85. Japan Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 98. India Allergy Immunotherapy Sales (K Units) by Company (2016-2021)
Table 99. India Allergy Immunotherapy Sales Market Share by Company (2016-2021)
Table 100. India Allergy Immunotherapy Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Allergy Immunotherapy Revenue Market Share by Company (2016-2021)
Table 102. India Allergy Immunotherapy Sales by Type (2016-2021) & (K Units)
Table 103. India Allergy Immunotherapy Sales Market Share by Type (2016-2021)
Table 104. India Allergy Immunotherapy Sales by Type (2022-2027) & (K Units)
Table 105. India Allergy Immunotherapy Sales Market Share by Type (2022-2027)
Table 106. India Allergy Immunotherapy Sales by Application (2016-2021) & (K Units)
Table 107. India Allergy Immunotherapy Sales Market Share by Application (2016-2021)
Table 108. India Allergy Immunotherapy Sales by Application (2022-2027) & (K Units)
Table 109. India Allergy Immunotherapy Sales Market Share by Application (2022-2027)
Table 110. ALK-Abello Corporation Information
Table 111. ALK-Abello Description and Business Overview
Table 112. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. ALK-Abello Allergy Immunotherapy Product
Table 114. ALK-Abello Recent Development
Table 115. Stallergenes Greer Corporation Information
Table 116. Stallergenes Greer Description and Business Overview
Table 117. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Stallergenes Greer Allergy Immunotherapy Product
Table 119. Stallergenes Greer Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck Allergy Immunotherapy Product
Table 124. Merck Recent Development
Table 125. Allergy Therapeutics Corporation Information
Table 126. Allergy Therapeutics Description and Business Overview
Table 127. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Allergy Therapeutics Allergy Immunotherapy Product
Table 129. Allergy Therapeutics Recent Development
Table 130. HAL Corporation Information
Table 131. HAL Description and Business Overview
Table 132. HAL Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. HAL Allergy Immunotherapy Product
Table 134. HAL Recent Development
Table 135. Holister Stier Corporation Information
Table 136. Holister Stier Description and Business Overview
Table 137. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Holister Stier Allergy Immunotherapy Product
Table 139. Holister Stier Recent Development
Table 140. Leti Corporation Information
Table 141. Leti Description and Business Overview
Table 142. Leti Allergy Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Leti Allergy Immunotherapy Product
Table 144. Leti Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Allergy Immunotherapy Distributors List
Table 148. Allergy Immunotherapy Customers List
Table 149. Allergy Immunotherapy Market Trends
Table 150. Allergy Immunotherapy Market Drivers
Table 151. Allergy Immunotherapy Market Challenges
Table 152. Allergy Immunotherapy Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapy Product Picture
Figure 2. Global Allergy Immunotherapy Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Allergy Immunotherapy Sales Market Share by Application in 2021 & 2027
Figure 6. Allergic Rhinitis Examples
Figure 7. Allergic Asthma Examples
Figure 8. Others Examples
Figure 9. Global Allergy Immunotherapy Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Allergy Immunotherapy Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Allergy Immunotherapy Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Allergy Immunotherapy Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Allergy Immunotherapy Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Allergy Immunotherapy Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Allergy Immunotherapy Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Allergy Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Allergy Immunotherapy Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Allergy Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Allergy Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Allergy Immunotherapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Allergy Immunotherapy Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Allergy Immunotherapy Players Market Share by Revenue in Allergy Immunotherapy: 2016 & 2020
Figure 28. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Allergy Immunotherapy Revenue Share by Type (2016-2021)
Figure 30. Global Allergy Immunotherapy Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Allergy Immunotherapy Revenue Share by Application (2016-2021)
Figure 32. Global Allergy Immunotherapy Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 34. North America Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 35. Europe Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 36. Europe Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 37. China Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 38. China Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 39. Japan Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 40. Japan Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 41. Southeast Asia Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 42. Southeast Asia Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 43. India Allergy Immunotherapy Sales Market Share by Type in 2020
Figure 44. India Allergy Immunotherapy Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Allergy Immunotherapy
Figure 47. Manufacturing Process Analysis of Allergy Immunotherapy
Figure 48. Allergy Immunotherapy Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の舌下アレルギー免疫療法市場規模・現状・予測（2021年-2027年） Sublingual Allergy Immunotherapy is a method of treating allergies by giving a drug under the tongue. Market Analysis and Insights: Global Sublingual Allergy Immunotherapy Market The global Sublingual Allergy Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million…- 世界のがん免疫療法市場規模・現状・予測（2021年-2027年） Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. Market Analysis and Insights: Global Cancer Immunotherapy Market The global Cancer Immunotherapy market size is projected to reach US$ 135140 million by 2027, from US$ …
- 世界のPD-1＆PD-L1免疫療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global PD-1 and PD-L1 Immunotherapy Market The global PD-1 and PD-L1 Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
- 世界の人間における猫アレルギー市場規模・現状・予測（2021年-2027年） Cat allergy in humans is an allergic reaction to one or more allergens produced by cats. The most common of these allergens are the glycoprotein Fel d 1, secreted by the cat's sebaceous glands and Fel d 4, which is expressed in saliva. An allergic reaction is a histamine reaction that is usually cha…
- 世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年） Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two typ…